Featured series 
Tag: George Demetri
-
Health
Bringing the cancer fight back down to earth
Halving deaths and other Biden goals are in reach, experts say, but let’s forget about “moonshot” and focus on resources and prevention.
-
Health
Sea squirt cancer drug under test
In the United States, researchers at three Harvard University-affiliated hospitals — Massachusetts General Hospital, Dana-Farber Cancer Institute, and Brigham and Women’s Hospital — have been testing a powerful drug on patients with breast, ovarian, and prostate cancer. “Tests show that the drug has been active enough to expand these trials,” says Bruce Chabner, a professor…
-
Health
FDA approves Gleevec as oral treatment for gastrointestinal stromal cancer
George Demetri, medical director of the Sarcoma Center at Dana-Farber Cancer Institute and associate professor of medicine at Harvard Medical School, was the lead investigator of a clinical study that looked at using Gleevec, an oral therapy, to treat occurrences of gastrointestinal stromal tumor. GIST, as it is known, is a rare form of sarcoma…
-
Health
New drug dissolves stomach tumors
Since July 2000, Harvard and Dana-Farber Cancer Institute researcher George Demetri and his colleagues have treated 148 patients with a rare, lethal stomach cancer known as GIST (Gastrointestinal Stromal Tumor). Eighty-six of them have been taking the drug long enough to evaluate its results, and half of these patients showed a 50 percent or greater…